Presentation to highlight preclinical data from the company’s lead cell therapy, ERNA-101, demonstrating potential to ...

Adagene’s most advanced SAFEbody candidate, ADG126, is currently in a Phase 1b/2 study in metastatic microsatellite-stable ...

Elevated interleukin-6 (IL-6) levels and increased density of regulatory T-cells (Tregs) in the tumor microenvironment (TME) were associated with poorer survival outcomes in chronic lymphocytic ...

Recent advances in cancer treatment highlight the potential of natural medicines to target the tumor vascular ...

Warming the extremities before bed has been shown to help people fall asleep more quickly. It does so as well as many ...

Tumors with higher stromal content may have a TME in an immune-overstimulated state, which could be a factor in their worse prognosis, the researchers suggested. Based on its associations with PD-L1 ...

Researchers ushered in a new chapter for personalized and precise cancer diagnostics using technology that can automatically ...

A new study has given leukemia researchers a powerful new dataset and collection of analytical methods—and a starting point for future research. One common treatment for leukemia is hematopoietic stem ...